The effects of SRS-A and histamine antagonists on antigen-induced contraction of guinea pig trachea

European Journal of Pharmacology
J F Burka, N A Paterson

Abstract

Spirally cut tracheae from actively sensitized guinea pigs were challenged with antigen in the presence and absence of indomethacin. In the absence of indomethacin, the SRS-A antagonist FPL55712, added 30 min before challenge had no effect on antigen-induced contraction (ATC) when added in concentrations less than or equal to 1.7 X 10(-6) M. However with the highest concentration employed (5.2 X 10(-6) M) the duration of ATC was reduced by 45%. Furthermore the enhancement by indomethacin of the peak height of ATC was reduced even by lower (5.2 X 10(-7) M) concentrations of FPL55712. The inhibition of FPL55712 was time-dependent, suggesting that its action was not confined to competitive receptor antagonism. Hence, although our previous data indicate that a lipoxygenase product is involved in ATC, the current findings suggest that lipoxygenase products in addition to SRS-A contribute to the response. THe H1-antagonists mepyramine, chlorpheniramine and diphenhydramine inhibited ATC only in the first minute, and the peak height was reduced only by diphenhydramine. The H2-antagonist cimetidine had no effect on ATC. These data suggest that the contribution of histamine to ATC is small, confined to the first minute following antigen ...Continue Reading

References

Jan 1, 1978·Biochemical Pharmacology·M Chasin, C Scott
Nov 17, 1977·Nature·G K Adams, L M Lichtenstein
May 1, 1971·Proceedings of the Society for Experimental Biology and Medicine·W J KoopmanK F Austen
Oct 17, 1973·Nature: New Biology·J AugsteinM L Tattersall
May 1, 1974·The Journal of Allergy and Clinical Immunology·P D JoinerF Hahn
Apr 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·L OrningB Samuelsson
Jun 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·R A LewisE J Corey
Jun 1, 1980·Prostaglandins·P J Gardiner, H O Collier
Apr 1, 1980·Prostaglandins·J F Burka, N A Paterson
Jun 1, 1980·British Journal of Pharmacology·J J Adcock, L G Garland
Aug 1, 1964·British Journal of Pharmacology and Chemotherapy·P A BERRY, H O COLLIER
Jun 1, 1965·The Journal of Pharmacy and Pharmacology·J W CONSTANTINE

❮ Previous
Next ❯

Citations

Dec 1, 1985·Agents and Actions·P O Ogunbiyi, P Eyre
Jul 23, 1987·European Journal of Pharmacology·B J UndemG K Adams
Jun 8, 1989·European Journal of Pharmacology·D G Redkar-Brown, D Aharony
Apr 6, 1993·European Journal of Pharmacology·R J HeaslipB M Weichman
Jan 1, 1988·International Journal of Immunopharmacology·A M Genaro, E Borda
Oct 1, 1996·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·K DobashiT Nakazawa
Jun 1, 1984·Journal of Veterinary Pharmacology and Therapeutics·P O Ogunbiyi, P Eyre
Mar 1, 1989·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·E RagazziG Fassina
Jul 1, 1985·Pediatric Pulmonology·M Souhrada, J F Souhrada
Jan 1, 1984·International Journal of Immunopharmacology·E BordaL Sterin-Borda
Dec 1, 1994·Prostaglandins, Leukotrienes, and Essential Fatty Acids·K InoueK Kimura

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.